Cargando…

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

OBJECTIVES: Compare the effect of apixaban and warfarin on coagulation and primary haemostasis biomarkers in atrial fibrillation (AF). METHODS: The biomarker substudy from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial included 4850 patients with AF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christersson, Christina, Wallentin, Lars, Andersson, Ulrika, Alexander, John H, Alings, Marco, De Caterina, Raffaele, Gersh, Bernard J, Granger, Christopher B, Halvorsen, Sigrun, Hanna, Michael, Huber, Kurt, Hylek, Elaine M, Lopes, Renato D, Oh, Byung-Hee, Siegbahn, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388910/ https://www.ncbi.nlm.nih.gov/pubmed/30209126 http://dx.doi.org/10.1136/heartjnl-2018-313351

Ejemplares similares

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
por: Pol, Tymon, et al.
Publicado: (2021)

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
por: Avezum, Alvaro, et al.
Publicado: (2018)

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014)

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
por: Batra, Gorav, et al.
Publicado: (2022)

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation
por: Melduni, Rowlens M, et al.
Publicado: (2020)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Comparative effectiveness of oral anticoagulants in everyday practice
por: Camm, A John, et al.
Publicado: (2021)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results
por: Nanavati, Parin P, et al.
Publicado: (2014)

A pilot study of angiotensin converting enzyme (ACE) genotype and return of spontaneous circulation following out-of-hospital cardiac arrest
por: Lindner, Thomas W, et al.
Publicado: (2014)

Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre
por: McMillan, Merlin Ranald, et al.
Publicado: (2014)

Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014)

Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use
por: Thomas, Dewi E, et al.
Publicado: (2015)

The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance
por: Phan, Thanh Trung, et al.
Publicado: (2015)

Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study
por: Sandgren, Emma, et al.
Publicado: (2015)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports
por: Chavez, Patricia, et al.
Publicado: (2015)

Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome
por: Raine, Daniel, et al.
Publicado: (2015)

Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes
por: Riding, Nathan R, et al.
Publicado: (2015)

A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
por: Ezzat, Vivienne A, et al.
Publicado: (2015)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
por: Kane, Sarah A, et al.
Publicado: (2016)

Estimated incidence and risk factors of sudden unexpected death
por: Lewis, Mary Elizabeth, et al.
Publicado: (2016)

Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study
por: Fauchier, Laurent, et al.
Publicado: (2015)

Exercise-related sudden cardiac arrest in London: incidence, survival and bystander response
por: Edwards, Melanie J, et al.
Publicado: (2015)

High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
por: Sandhu, Roopinder K, et al.
Publicado: (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Long-term outcomes after ablation of persistent atrial fibrillation: an observational study over 6 years
por: Wynn, Gareth J, et al.
Publicado: (2016)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Low incidence of left atrial delayed enhancement with MRI in patients with AF: a single-centre experience
por: Bois, John P, et al.
Publicado: (2017)

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
por: Murakami, Naoto, et al.
Publicado: (2017)

Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition
por: Harper, Mariko W, et al.
Publicado: (2018)

Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES)
por: Malik, Rehan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g51atclc6jm9fdvu1083vl4jen